Parallel Advisors’s Altimmune ALT Stock Holding History

Parallel Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122	Hold	40	–	–	﹤0.01%	3871
2026 Q1	$123	Hold	40	–	–	﹤0.01%	3780
2025 Q4	$144	Hold	40	–	–	﹤0.01%	3532
2025 Q3	$151	Hold	40	–	–	﹤0.01%	3458
2025 Q2	$155	Hold	40	–	–	﹤0.01%	3435
2025 Q1	$200	Hold	40	–	–	﹤0.01%	3378
2024 Q4	$288	Hold	40	–	–	﹤0.01%	3324
2024 Q3	$246	Hold	40	–	–	﹤0.01%	3274
2024 Q2	$266	Hold	40	–	–	﹤0.01%	3170
2024 Q1	$407	Hold	40	–	–	﹤0.01%	3087
2023 Q4	$450	Hold	40	–	–	﹤0.01%	3073
2023 Q3	$104	Hold	40	–	–	﹤0.01%	3277
2023 Q2	$141	Hold	40	–	–	﹤0.01%	3263
2023 Q1	$169	Hold	40	–	–	﹤0.01%	3296
2022 Q4	$658	Hold	40	–	–	﹤0.01%	2982
2022 Q3	$1K	Sell	40 -400	-91%	-$5.91K	﹤0.01%	2835
2022 Q2	$5K	Buy	440 +386	+715%	+$2.38K	﹤0.01%	2237
2022 Q1	$0	Sell	54 -371	-87%	-$2.73K	﹤0.01%	2940
2021 Q4	$4K	Sell	425 -309	-42%	-$3.28K	﹤0.01%	2450
2021 Q3	$8K	Hold	734	–	–	﹤0.01%	2155
2021 Q2	$7K	Hold	734	–	–	﹤0.01%	2141
2021 Q1	$10K	Buy	+734	New	+$11.9K	﹤0.01%	1907

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parallel Advisors's ALT Position: Q2 2026 in Review

Parallel Advisors held its Altimmune (ALT) position steady in Q2 2026 at 40 shares worth $122. The position accounts for ﹤0.01% of the portfolio, ranked #3871.

Parallel Advisors first reported a position in ALT in Q1 2021 and has held it in 22 quarters since. The position peaked at $10K in Q1 2021. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Parallel Advisors held 40 shares of Altimmune worth $122 as of Q2 2026.
Parallel Advisors left its Altimmune share count unchanged in Q2 2026.
Altimmune made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3871 holding.
Parallel Advisors first reported a position in Altimmune in Q1 2021 and has held it in 22 quarters since.
Parallel Advisors's Altimmune position peaked at $10K in Q1 2021.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.